go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

CMD GmbH

Organization type
RDM medtech
Region
Upper Austria
Topic
Other
Details

intelligent motion gmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
electromechanical medical devices
Details

GE Healthcare Austria GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
diagnostic and therapeutic radiation devices
Details

METEKA GmbH

Organization type
RDM medtech
Region
Styria
Cluster
Human.technology Styria
Topic
Other
Details

Contact



Contact: